SAN ANTONIO--(BUSINESS WIRE)--Doctors Pramod Kumar Mishra, Ph.D. in Microbiology and Immunology, and Niti Vanee, Ph.D. in Bioinformatics and Systems Biology, have formed iGenomeDx, Inc. and are building a new Pharmacogenomics laboratory in San Antonio, Texas.
The science is called “Pharmacogenomics,” but most call it Precision Medicine or Personalized Medication. Whatever it’s called, it is the simple testing of your personal genetic factors. This testing has become the most accurate method of determining appropriate drug dosages, reduced polypharmacy, and an overall decrease in the cost of health care. It decreases the cost of health care because it decreases the number of adverse drug reactions, the length of time a patient relies on medication, the number of medications patients must take to find an effective therapy, the effects of a disease on the body through early detection, and the number of failed drug trials.
If your physician isn’t using this attested, insurance-paying, low-cost practice now, he or she will be very soon.
Rudy W. De La Garza, Board member of iGenomeDx, Inc. and former US Marine with two purples, receives his medical treatment from the VA. “If the VA were already using this testing, it could save the government millions if not billions of dollars annually,” said Mr. De La Garza. “As for me personally,” Mr. De La Garza continues, “I wouldn’t have to wait to have all the bad side effects before they change my medication or dosage. One day soon, the VA will catch up with the rest of the world.”
The iGenomeDx laboratory for the testing of your personal genetic factors is scheduled to open in San Antonio. The location has been leased, and the equipment ordered. There is a great opportunity for investors at this time. The investment, for preferred shares with a promissory note paying 12% annually over two years, is for as little as $5,000.00.
This is not an offer to sell or a solicitation of any offer to buy any securities. Offers are made only by prospects or other offering materials. To obtain further information, you must complete our investor questionnaire and meet the suitability standards required by law.
For this information, please go to http://igdxppm.com/